Protara Therapeutics Cash Flow Statement (2014-2015) | TARA

Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015
Operating Activities
Net Income -2.76M-2.54M0.15M-3.29M
Share-based Compensation 0.02M0.03M0.18M0.23M0.41M0.48M0.61M0.67M
Gains from Investment Securities 1.13M0.66M1.64M1.76M1.80M
Non-cash Items 0.58M7.71M0.59M19.77M0.78M
Cash from Operations -1.56M-2.67M-3.71M-2.05M-3.87M-4.60M-3.91M-5.19M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.74M0.00M-0.20M-0.22M-0.17M-0.07M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Change in Working Capital
Change in Receivables -0.01M0.02M0.01M0.30M-0.11M0.02M-0.18M
Change in Accured Expenses 0.59M1.03M-0.34M-0.32M0.30M0.07M0.12M0.77M
Other Working Capital Changes 0.26M1.22M-4.43M-0.10M0.52M-0.24M0.72M
Investing Activities
Capital Expenditures 0.01M0.01M0.01M0.03M0.14M0.03M
Change in Acquisitions & Divestments 2.35M1.23M18.94M2.96M12.36M28.43M31.75M
Cash from Investing Activities 2.35M-16.83M-1.69M3.68M-55.18M11.58M23.06M9.22M
Financing Activities
Other financing activities 0.01M
Cash from Financing Activities -0.01M63.97M0.04M0.06M
Additional items
Exchange Rate Effect -0.02M-0.05M
Change in Cash 0.79M5.06M-5.41M65.60M-59.06M7.03M19.17M4.05M
Beginning Cash Balance 2.79M3.59M8.65M3.24M68.84M9.78M16.82M-4.05M
Free Cash Flow -1.56M-2.67M-3.71M-2.06M-3.88M-4.63M-4.04M-5.21M
Net Cash Flow 0.79M-19.50M-5.41M65.60M-59.06M6.98M19.19M4.09M